Geneoscopy
Geneoscopy Countersues Exact Sciences Over Patent Central to Cologuard
Geneoscopy alleges that Exact Sciences has misappropriated its trade secrets, breached contract, and engaged in unfair competition.
Geneoscopy Nabs FDA Approval for Stool-Based Colorectal Cancer Screening Test
The St. Louis, Missouri company's ColoSense assay is likely going to compete with Exact Sciences' Cologuard CRC screening test.
Geneoscopy, Adiso Therapeutics Partner to Advance Inflammatory Bowel Disease Therapy
Adiso will use Geneoscopy's stool-based RNA platform to assess patient response to its candidate IBD therapy in a Phase II trial.